1 Addiction Medicine 2013 Pharmacotherapy for alcohol dependence Part I: alcohol withdrawal Roy M Stein, MD Durham Veterans Affairs Medical Center Duke University School of Medicine
2 Objectives Identify goals in treatment of alcohol withdrawal. Identify indications for ambulatory vs. inpatient detoxification. Compare symptom-triggered vs. fixed-taper treatment strategies. Identify first-line and alternative medication options. View detoxification in the broader context of personal recovery. Share experience with fellow clinicians.
3 Case 1 71y/o divorced, well-educated, retired male. Recently moved to the area.
4 primary care new patient appointment h/o alcohol abuse, sober x 22 months had alcohol counseling, attended AA h/o depression, on citalopram x 4 years hypertension; chronic pancreatitis; UGI bleed Alcohol Use Disorders Identification Test- Consumption Questions (AUDIT-C): negative Depression screen (PHQ-2): negative Continue citalopram, RTC 6 months.
5 5 months later: Emergency Department I need alcohol detox. Relapsed 3 weeks earlier. Consuming 8.5 drinks/day. Last drink eight hours ago. One prior inpatient detox for uncomplicated w/d. Mood anxious. P 110. No other withdrawal symptoms.
6 Clinical management Is medical detoxification warranted? If so, Setting: ambulatory vs. inpatient? Choice of medication? Dosing/monitoring strategy?
7 Goals of detoxification Patient Safety Prevent complicated withdrawal: seizures, delirium. Prevent medical complications, e.g., angina. Prevent adverse medication effects (e.g., falls, impaired cognition.) Patient comfort (suppress symptoms) Prepare for ongoing recovery. Enhance patient motivation. Establish concrete plan for next phase, which may include relapse prevention medication.
9 Initial evaluation Medical/psychiatric history Other substances, including nicotine Physical examination Mental status examination Suicidal ideation Hallucinations, delusions Cognitive status Labs Blood alcohol level, urine drug screen Electrolytes including Mg++ Liver function tests CIWA-Ar
10 Ambulatory alcohol detoxification Stable medically and psychiatrically No history of complicated withdrawal Able to return for daily visits without driving. Reliable friend or relative. Prescribe 24 hr med supply at each visit Safe and effective for appropriately selected patients.
11 Ambulatory alcohol detoxification Hayashida M et al. NEJM, male veterans, low SES, mild-moderate withdrawal. No h/o seizures, delirium. Randomized to inpatient vs. outpatient detox Higher completion rate for IP (95 vs. 72%). No complications, much lower cost with OP. No difference in outcome at 6 months.
13 Advantages of benzodiazepines Suppress symptoms Prevent seizures Favorable safety profile Multiple routes of administration oral intravenous intramuscular
14 Risks of benzodiazepines Cognitive impairment Incoordination, falls Impaired driving accidents Euphoria, reinforcement Abuse and dependence Synergism with alcohol
15 Choose benzodiazepine based on pharmacokinetics Route of administration Rate of absorption Permeability across blood/brain barrier Mechanisms of metabolism, elimination Elimination half-life Active metabolites
16 Benzodiazepines Onset (po) half-life (h) metabolism admin lorazepam intermed 14 glucuron po, iv, sl oxazepam* slow 9 glucuron po diazepam* fast 40, 60 CYP450 po, iv, im chlordiazepoxide* intermed 20, 30, 60 CYP450 po clonazepam intermed CYP450 po * FDA-approved for treatment of alcohol withdrawal.
17 Systematic review of benzodiazepine treatment of alcohol withdrawal syndrome. 64 studies, 4309 patients BZ s superior to placebo in preventing seizures. Non-significant trend favoring chlordiazepoxide over other BZ s. One study: symptom-triggered therapy with CIWA superior to fixed BZ schedule. Minozzi S et al. Cochrane Library
18 In this case MD in ED initiated ambulatory detox. Chlordiazepoxide 25 mg q4h prn (#6, NR) Instructions to patient: No driving. Return for re-evaluation within 24 hours.
19 Pt did not return to complete ambulatory detox, but did return to ED 8 days later Continued to consume 8-10 drinks/day Last drink 8 hours ago. Anxious mood, anhedonia, nausea, anorexia, insomnia, no SI. Mild tremor. P 111. BP 150/95 Admitted for detox.
20 Benzodiazepine dosing strategies Fixed taper +/- prn s. Simple Monitor VS, sedation, withdrawal symptoms (?) Fine for the average patient; over- or under-medicates others. Symptom-triggered strategy. Titrate dose to standardized assessment of withdrawal severity, such as CIWA-Ar. Diazepam-loading is one form. Regardless of strategy, systematic monitoring of clinical response is essential.
21 Case 1: chlordiazepoxide fixed taper Pulse SBP Librium
22 Mood and withdrawal symptoms resolved rapidly in the hospital. Patient endorsed goal of abstinence and agreed to outpatient treatment. Would you offer relapse prevention medications at this point?
23 7 days post discharge: SUD Clinic evaluation 2-3 glasses of wine daily since discharge. Considered himself in recovery for 2 years though drinking wine (not liquor) regularly throughout. Ambivalence: would like to be sober, i.e., drink less, to please daughter and not be encumbered by addiction. Recognizes negative effects on physical health and memory. I know I need to quit, it s just hard.
24 1 month post d/c: SUD Psychiatry evaluation 2-3 glasses of wine most days. Self-diagnosed dysthymic disorder Exercise 3x/week, attends adult ed classes. New relationship. Dx: alcohol dependence, dysthymic disorder, h/o major depressive disorder. Individual and group psychotherapy in SUD Clinic. Recommended AA. Continue citalopram. Naltrexone mg daily.
25 During the next 12 months Multiple cycles of remission-relapse-detox. Admissions for alcohol-related cardiac arrhythmia and two medication overdoses. Inconsistent treatment adherence (naltrexone, acamprosate, therapy appointments). Residential rehab left early. The hospital instituted symptom-triggered detox protocol using CIWA-Ar.
26 Symptom-triggered treatment of alcohol withdrawal Saitz R, Mayo-Smith MF et al. Individualized treatment for alcohol withdrawal: a randomized double-blind controlled trial. JAMA. 1994;272: BZ dosing based on CIWA score. Protocol-driven order set. Requires nurse training, commitment. Results: Briefer detoxification. Lower average BZ administration. Avoid under-treatment of severe withdrawal.
27 Clinical Institute Withdrawal Assessment Alcohol, Revised (CIWA-Ar) Nausea/vomiting 0-7 Tremor 0-7 Paroxysmal Sweats 0-7 Anxiety 0-7 Agitation 0-7 Tactile Disturbances 0-7 Auditory Disturbances 0-7 Visual Disturbances 0-7 Headache, Fullness in Head 0-7 Orientation and Clouding of Sensorium 0-4
28 Clinical Institute Withdrawal Assessment of Alcohol, Revised (CIWA-Ar) Maximum score= minimal or no withdrawal 9-15 mild moderate >20 severe withdrawal
30 Nursing: Initial CIWA-Ar score No chlordiazepoxide is needed now. 2. Repeat vital signs and CIWA-Ar q4 hours x 3; if all CIWA-Ar scores are 0-8, may go to daily assessments. 3. If CIWA score increases to 9 or above, go to protocol below. ACCEPT EDIT CANCEL
31 Nursing: Initial CIWA-Ar score Nurse will call/notify MD of administration of loading dose of chlordiazepoxide 50 mg PO. 2. Administer chlordiazepoxide 50 mg PO and repeat vital signs in 2 hours; then go to every 4 hour schedule below. 3. If each CIWA-Ar score remains 9-15, give chlordiazepoxide 50 mg, not to exceed 300 mg in 24 hours. 4. If CIWA score increases to 16 or above, go to protocol below. 5. If CIWA score decreases to 0-8, return to lower protocol. 6. Hold chlordiazepoxide if patient is over-sedated or respiratory rate is < 10. ACCEPT EDIT CANCEL
32 Nursing: Initial CIWA-Ar score 16 or above 1. Give chlordiazepoxide 50 mg PO and call MD for individualized orders. 2. Continue vitals signs and CIWA-Ar every 4 hours while awaiting individualized orders. 3. Hold chlordiazepoxide if patient is over-sedated or respiratory rate is < 10. ACCEPT EDIT CANCEL
35 Case 1: symptom-triggered detox Pulse SBP Librium CIWA
36 Psychiatry admissions treated for alcohol withdrawal pre- and post- initiation of CIWA protocol Fixed taper: 54 patients Symptom-triggered: 47 patients Taper CIWA 2 0 Length of stay (days) Days of BZ administration BZ doses
37 Medicine admissions treated for alcohol withdrawal pre- and post-initiation of CIWA protocol Fixed taper: 15 patients Symptom-triggered: 21 patients Length of Stay (days) BZ doses Taper CIWA
38 Turning point Pt. drove, intoxicated, to convenience store, where he fell. Brought to ED by ambulance. Consuming up to 16 drinks daily x 3 weeks. Tremulous, weak, nausea, anorexia Mood depressed. Affect dysphoric, reactive. Admitted, completed uneventful detox with symptom-triggered protocol.
39 Prior to discharge a family conference was held in which the patient agreed, as conditions of continued family contact, to: Sell his car and give up driving. Resume consistent AA Resume outpatient therapy. Resume naltrexone.
40 14 months present Sustained abstinence. Daily AA. Gradual restoration of family relationships. Resumed driving after 9 months sobriety. Completed courses of group cognitive-behavioral therapy for alcohol relapse prevention and depression. Mirtazapine, naltrexone
41 Alternative medications for alcohol withdrawal Antiadrenergic agents β-blockers α 2 -agonists Anticonvulsants
42 Antiadrenergic agents β-blockers Atenolol Metoprolol Propranolol α 2 -agonists Presynaptic inhibition of NE release. Clonidine (oral, transdermal) Dexmedetomidine (IV for use in ICU) Less respiratory depression than propofol Endotracheal intubation is not required.
43 Antiadrenergic agents Both classes reduce sympathetic overdrive. Both may reduce other symptoms: Anxiety Craving Neither class prevents seizures. May be useful as adjuncts to conventional treatment, but never as monotherapy.
44 Anticonvulsants: Carbamazepine 88 men with severe alcohol withdrawal. 66 completed the study. CBZ 800 mg/day vs. OXZP 120 mg/day Comparable outcomes overall. CBZ group had lower psychological distress on days 3-7. Malcolm R, Ballenger JC, Sturgis ET, Anton R. (1989). Double-blind, controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 146(5):
45 Systematic review of anticonvulsant treatment of AWS. 56 studies, 4076 participants CBZ superior to oxazepam or lorazepam with more favorable side effect profile Otherwise, no evidence of advantage of anticonvulsants over placebo or other drugs. Minozzi S et al. Cochrane Library
46 Anticonvulsants: Gabapentin 100 subjects seeking OP detox, CIWA>10. Treated x 4 days with: Gabapentin > 800 Gabapentin 900 -> 600 Lorazepam 6 -> 4 Assessed days 1-4, 5,7,12 Relative to lorazepam, GB was well-tolerated, effective in relieving withdrawal symptoms, lower probability of drinking Myrick H, Malcolm R et al. (2009). A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res 33(9):
47 Gabapentin for alcohol detox in clinical practice Local pockets of active use. Extent of use in real-world clinical practice? One clinical approach for ambulatory detox: Standard ambulatory detox criteria. 9-day taper, staring at 400 mg tid. Follow-up at 24 hours, then as needed. Gabapentin may be maintained for relapse prevention in some cases. J. Gochnour, MD. Personal communication.
48 Alternative strategy to assess and manage withdrawal Type Process NT Pharmacotherapy A CNS excitation GABA GLUT benzodiazepines anticonvulsants B Adrenergic hyperactivity NE β-blockers α 2 -agonists C Delirium/psychosis DA DA antagonists Paolo B. DePetrillo & Mark K. McDonough, PO Box 530, Glen Echo, MD USA 20812; ( ;http://www.sagetalk.com Stanley KM et al. Pharmacotherapy 2005;25(8): Nejad SH et al. Case : A 55-Year-Old Man with Alcoholism, Recurrent Seizures, and Agitation. N Engl J Med 367;25 December 20, 2012.
49 Protracted abstinence syndrome negative emotionality + sensitivity to stress + sleep disturbance return to drinking Are the processes in acute withdrawal mechanistically linked to those that persist during protracted abstinence? Heilig M, Egli M, Crabbe JC, Becker HC. Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addict Biol Apr;15(2):169-84
50 And this just in Walker B et al. Ethanol for alcohol withdrawal: the end of an era. J Trauma Acute Care Surg. 2013;74:
51 Summary Benzodiazepines remain first-line treatment. Supplement thiamine (oral vs. parenteral). Symptom-triggered therapy with CIWA is safe and reduces average BZ exposure and length of stay. Ambulatory detoxification is safe and effective for selected patients. Anticonvulsants may be a safe, effective alternative, but their role is not fully established. Anti-adrenergics useful as adjuncts, not as monotherapy. Considering protracted abstinence syndrome, treatment of withdrawal may merge into relapse prevention.
Outpatient Treatment of Alcohol Withdrawal Daniel Duhigg, DO, MBA DSM V criteria for Alcohol Withdrawal A. Cessation or reduction of heavy/prolonged alcohol use B. 2 or more of the following in hours to
Symptom Based Alcohol Withdrawal Treatment -Small Rural Hospital- Presenter CDR Dwight Humpherys, DO email@example.com Idaho State University Baccalaureate Nursing Program Lake Erie College of Osteopathic
Alcohol Withdrawal Syndromes Should You Treat This Patient s Alcohol Withdrawal With Benzodiazepines?! Meta-analysis of RCTs of benzodiazepines for the treatment of alcohol withdrawal! 11 RCTs identified,
Alcohol Withdrawal Syndrome & CIWA Assessment Alcohol Withdrawal Syndrome is a set of symptoms that can occur when an individual reduces or stops alcoholic consumption after long periods of use. Prolonged
Case 48 year old man admitted complaining of hallucinations. Mild hallucinations for a year. Worsened tremor for 3 weeks and then markedly worse hallucinations last 2 days History of psoriatic arthritis,
Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth I. II. Background A. AWS can occur in anyone who consumes alcohol B. Risk correlates
Alcohol Withdrawal Recognition and Treatment Thomas Meyer BS EMS, MICP SREMSC Page 1 Purpose As EMTs a mantle of responsibility is placed upon you to ensure the safety and well-being of those in your charge
SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT OF ALCOHOL MISUSE Date: March 2015 1 1. Introduction Alcohol misuse is a major public health problem in Camden with high rates of hospital
1 Chapter 36. Substance-Related, Self-Assessment Questions 1. According to recent US national estimates, which of the following substances is associated with the highest incidence of new drug initiates
ALCOHOL ABUSE AND WITHDRAWAL SYNDROME IN THE ELDERLY Colin Muscat Family Medicine Case 90 year old Female Lives with son on vacation Admitted for FTT Consult -? GARP Develops increasing confusion during
Alcohol Withdrawal Sorrento, Italy (September 19, 2007) Lewis R. Goldfrank, MD Professor and Chairman, Emergency Medicine New York University School of Medicine Director, Emergency Medicine Bellevue Hospital/NYU
Alcohol Abuse and Addiction Management Protocol All Team Members: Patient Self-Management Education and Support Alcohol is the most commonly abused drug in the United States. About 18 million people in
RCGP Conference May 2011 Community Based Medically Assisted Alcohol Withdrawal THE BASICS An option for consideration World Health Organisation 2011 Alcohol is the world s third largest risk factor for
ALCOHOL DETOXIFICATION (IN-PATIENTS) PRESCRIBING GUIDELINE Authors Sponsor Responsible committee Ratified by Consultant Psychiatrist; Pharmacist Team Manager Medical Director Medicines Management Group
Abteilung Praxisentwicklung Pflege Alcohol withdrawal A challenge in caring for patients after heart surgery Wolfgang Hasemann, RN, PhD Deborah Leuenberger, MScN.cand. June 2015 Content Alcohol consumption
Alcohol Dependence and Motivational Interviewing Assessment of Alcohol Misuse Checklist Establish rapport patients are often resistant Longitudinal history of alcohol use Assess additional drug use Establish
Benzodiazepines: A Model for Central Nervous System (CNS) Depressants Objectives Summarize the basic mechanism by which benzodiazepines work in the brain. Describe two strategies for reducing and/or eliminating
SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] I. Definitions: Detoxification is the process of interrupting the momentum of compulsive drug and/or alcohol use in an individual
Comprehensive ehavioral Care, Inc. delivery system that does not include sufficient alternatives to a particular LOC and a particular patient. Therefore, CompCare considers at least the following factors
CHAPTER 75-09.1-08 SOCIAL DETOXIFICATION ASAM LEVEL III.2-D Section 75-09.1-08-01 De nitions 75-09.1-08-02 Program Criteria 75-09.1-08-03 Provider Criteria 75-09.1-08-04 Admission and Continued Stay Criteria
Alcohol Withdrawal Julie Teater, MD Associate Professor - Clinical Department of Psychiatry The Ohio State University Wexner Medical Center Learning Goals/Objectives Discuss the diagnosis of and screening
Julie Teater, MD Associate Professor - Clinical Department of Psychiatry The Ohio State University Wexner Medical Center Learning Goals/Objectives Discuss the diagnosis of and screening for alcohol use
VAMC Detoxification Decision Tree Updated May 2006 INTOXICATED PATIENTS AND DETOXIFICATION Patients often present for evaluation of substance use and possible detoxification. There are certain decisions
.6.3 Self-medication Self-medication presents a risk during alcohol withdrawal, particularly when there is minimal supervision (low level and medium level 1 settings). Inform patients of the risk of selfmedication
Phenobarbital in Severe Alcohol Withdrawal Syndrome Jordan Rowe Pharm.D. Candidate UAMS College of Pharmacy Disclosure: No relevant financial relationship exists. Objectives 1. Describe the pathophysiology
Audit of Alcohol Detoxification Prescribing Observatory for Mental Health (POMH-UK) Regional Event Wakefield 4th December 2013 definition and guidance Duncan Raistrick Leeds Addiction Unit Detoxification
GP Drug & Alcohol Supplement No.7 May 1997 This is the seventh of the monthly Drug and Alcohol Supplements prepared for Central Coast GPs. Detoxification from Alcohol Dr Tony Gill Introduction The management
University of Michigan Alcohol Withdrawal Guidelines Overview The following document contains the University of Michigan Alcohol Withdrawal Guidelines. These guidelines were developed through an intensive
Dr IM Joubert Alcohol and nicotine are widely abused substances and are often used together One study showed that 15% of patients visiting a primary care practice for any reason had either an at-risk pattern
Treatment of Alcohol Withdrawal Hugh Myrick, M.D., and Raymond F. Anton, M.D. Appropriate treatment of alcohol withdrawal (AW) can relieve the patient s discomfort, prevent the development of more serious
A COMPARATIVE STUDY OF EFFICACY & TOLERABILITY OF LORAZEPAM AND GABAPENTIN IN THE TREATMENT OF ALCOHOL WITHDRAWAL SYNDROME Dr. Ashutosh Chourishi,* Dr. O.P. Raichandani**, Dr. Sunita Chandraker***, Dr.
Medical Necessity In considering the appropriateness of any level of care, the four basic elements of Medical Necessity should be met: 1. A diagnosis as defined by standard diagnosis nomenclatures (DSM
Supported Alcohol Withdrawal Treatment Information Alcohol Liaison Service What is Alcohol Withdrawal Syndrome? If you are dependent on alcohol and suddenly stop drinking or you are admitted to hospital
Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score
Pain Medication Taper Regimen Time frame to taper off 30-60 days Medication to taper Taper Regimen Comments Methadone Taper by no more than 25% Morphine Taper by no more than 25% Tramadol Taper by no more
GUIDELINES FOR COMMUNITY ALCOHOL DETOXIFICATION IN SHARED CARE Dr Millicent Chikoore MBBS MRCPsych Dr O Lagundoye MBBS MRCPsych Community based alcohol detoxification is a safe and effective option for
ANCILLARY STABILIZATION AND WITHDRAWAL The Why And How Of Stabilizing The Patient In A Comprehensive Treatment Setting About CASAColumbia A science-based, multidisciplinary organization Focused on transforming
Height Weight Allergies Please consider these other order sets: -Medical-Surgical Electrolyte Replacement -Critical Care Electrolyte Replacement General Discontinue all previously ordered benzodiazepines
Alcohol Withdrawal in the AMU Dr Ewan Forrest Glasgow Royal Infirmary The Society for Acute Medicine, 7 th International Conference, 3-4 October 2013 AWS: The Scale of the Problem Hospital Admissions (England):
Page 1 of 12 TITLE: ALCOHOL WITHDRAWAL (AWD) SYMPTOM-TRIGGERED THERAPY GUIDELINES (PILOT) FOR MEDICAL PATIENTS (NYP/CU: EMERGENCY DEPARTMENT, MEDICAL ICU/A AND B, 6GN/S, AND 7GS) GUIDELINE: Alcohol Withdrawal
Chapter 5 Alcohol withdrawal management Alcohol Withdrawal Syndrome: Clinical Presentation This section discusses the clinical signs and symptoms, onset and duration, and common complications of alcohol
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
The Treatment of Acute Alcohol Withdrawal General Internal Medicine Grand Rounds February 14, 2012 Julie Taub, MD Denver Health & Hospital Authority, Denver CO Pharmacology Ethanol Benzodiazepines Chlormethiazole
Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,
1 Live Person Simulation Scenario Psychiatric and Mental Health Nursing (Sandra) I. Scenario Title: Assessment Interview & Medication Administration for a Client with Clinical Depression & Alcohol Abuse
E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population
Strategies for Addressing Alcohol Dependence Jennifer McNeely, MD, MS Assistant Professor NYU School of Medicine Disclosures No relevant financial relationships to disclose Current research grant support:
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,
Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 General Vital Signs
Does This Hospital Serve Cocktails? Alcohol Withdrawal: A Nursing Perspective Written and presented by: Susan Laffan, RN, CCHP-RN, CCHP-A Disclaimer: This speaker has no financial disclaimers to report.
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
Treatment of Alcoholism Why is it important Prevents further to body by getting people off alcohol. Can prevent death. Helps keep health insurance down. Provides assistance so alcoholics don t t have to
Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 Discontinue all lorazepam
Experience with an Adult Alcohol Withdrawal Syndrome Practice Guideline in Internal Medicine Patients Karen M. Stanley, M.S., Cathy L. Worrall, Pharm.D., FAPhA, Shayna L. Lunsford, M.S., Kit N. Simpson,
Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions
Journal of Pharmacy and Pharmacology (014) 1-7 D DAVID PUBLISHING Phenobarbital Use as Adjunct to Benzodiazepines in the Treatment of Severe Alcohol Withdrawal Cristina Roman, Sibusisiwe Gumbo and Kevin
Didactic Series Office-based Treatment for Substance Abuse Disorder in HIV-infected Patients Jacqueline Tulsky, MD Pacific AETC June 26, 2014 ACCREDITATION STATEMENT: University of California, San Diego
Alcohol Overuse and Abuse ACLI Medical Section CME Meeting February 23, 2015 Daniel Z. Lieberman, MD Professor and Vice Chair Department of Psychiatry George Washington University Alcohol OVERVIEW Definitions
SCREENING FOR DRUG AND ALCOHOL ABUSE AND TREATMENT OPTIONS Gretchen Nickell, DO, FACOI DME/Internal Medicine Program Director East Liverpool City Hospital We will discuss The local problem How to quickly
Commonwealth of Massachusetts Board of Registration in Medicine Quality and Patient Safety Division Advisory Alcohol Screening and Management Protocols July 2013 Background The Quality and Patient Safety
TREATMENT GUIDELINES Psychopharmacotherapy for Children and Adolescents Guideline 7 Psychopharmacotherapy for Children and Adolescents Description There are few controlled trials to guide practitioners
Care of the Patient Undergoing Alcohol Withdrawal Meggen Platzar RN, BSN, CMSRN Jennifer Wilhelm RN, BSN, CMSRN If you know someone who tries to drown their sorrows, you might tell them sorrows know how
Shared Care Guideline for Prescription and monitoring of Naltrexone Hydrochloride in alcohol dependence Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist,
Prescription Drug Abuse Introduction Most people take medicines only for the reasons their health care providers prescribe them. But millions of people around the world have used prescription drugs for
Mayo Clin Proc, July 2001, Vol 76 Alcohol Withdrawal in Inpatients 695 Original Article Symptom-Triggered Therapy for Alcohol Withdrawal Syndrome in Medical Inpatients THOMAS M. JAEGER, MD; ROBERT H. LOHR,
Symptom-Triggered Alcohol Detoxification: A Guideline for use in the Clinical Decisions Unit of the Emergency Department. Dr Eugene Cassidy, Liaison Psychiatry; Dr Io har O Sulliva, E erge cy Department,
Alcohol Liaison Service Alcohol Withdrawal Information Alcohol withdrawal If you are dependent on alcohol and suddenly stop drinking, there are a series of symptoms that you may experience. These include:
Addiction Medicine 2014 Update on Current/New/Anticipated Medications for Alcohol Use Disorders J.C. Garbutt, MD Department of Psychiatry and Bowles Center for Alcohol Studies School of Medicine, University
01736 850006 www.bosencefarm.co.uk DRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES An environment for change Boswyns provides medically-led drug and alcohol assessment, detoxification and stabilisation.
Alcohol Withdrawal Syndrome MAX BAYARD, M.D., JONAH MCINTYRE, M.D., KEITH R. HILL, M.D., and JACK WOODSIDE, JR., M.D. East Tennessee State University James H. Quillen College of Medicine, Johnson City,
Alcoholism Lecture Alcohol Withdrawal and Delirium Jeff Thiele MD 11-4-03 Alcohol intoxication occurs at blood levels of.050 to.080 depending on your criteria. In MO the legal definition is now a BAL of.80
Alcohol addiction treatment VERESIES CLINIC offers treatment of alcohol dependence. The program is offered both as an inpatient and outpatient program. It offers an intensive program of personal Psychological
Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine firstname.lastname@example.org
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
E-Resource October, 2014 Prescribing and Tapering Benzodiazepines The use of benzodiazepines has grown over time and evidence has shown that long term use of these drugs has very little benefit with many
Development and Implementation of an Evidence-Based Alcohol Withdrawal Order Set Kathleen Lenaghan MSN, RN-BC 1 2 Genesis Medical Center Davenport, Iowa Objectives Identify the process of developing and
Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence Issued: February 2011 guidance.nice.org.uk/cg115 NICE has accredited the process used by the Centre
Vivitrol Pilot Study: SEMCA/Treatment Providers Collaborative Efforts with the treatment of Opioid Dependent Clients Hakeem Lumumba, PhD, CAADC SEMCA Scott Schadel, MSW, LMSW, CAADC HEGIRA PROGRAMS, INC.
Detoxification of Chemically Dependent Inmates Federal Bureau of Prisons Clinical Practice Guidelines February 2014 Clinical guidelines are made available to the public for informational purposes only.
1.0 Introduction Medications are used in the treatment of drug, alcohol and nicotine dependence to manage withdrawal during detoxification, stabilisation and substitution as well as for relapse prevention,
Weight (kg) REFER TO THE ALLERGY SCREEN IN MEDITECH FOR ALLERGY INFORMATION To complete the order form, fill in the required blanks and/or check the appropriate boxes. To delete orders, draw one line through
THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES PURPOSE: The goal of this document is to describe the
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents
UCLA-SAPC Lecture Series March 13, 2015 Gary Tsai, M.D. Medical Director Substance Abuse Prevention and Control Neurobiology 101 Neuroscience of Addiction & Recovery Medication-Assisted Treatment (MAT)
Glasgow Assessment and Management of Alcohol If you would like further information or advice on the alcohol screening and withdrawal management guideline(gmaws) please contact your local acute addiction